GAFA
OGN icon

Garton & Associates Financial Advisors’s Organon & Co OGN Stock Holding History

Garton & Associates Financial Advisors’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25
Closed -$179 – 513
2025
Q4 		$179 Buy
+25
New +$198 ﹤0.01% 1157

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KBG
Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Garton & Associates Financial Advisors's OGN Position: Q1 2026 in Review

Garton & Associates Financial Advisors sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 25 shares — an estimated $179 sold.

Garton & Associates Financial Advisors first reported a position in OGN in Q4 2025 and held it in 1 quarter. The position peaked at $179 in Q4 2025. 607 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Garton & Associates Financial Advisors reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Garton & Associates Financial Advisors sold 25 Organon & Co shares in Q1 2026, an estimated $179.
  • Garton & Associates Financial Advisors first reported a position in Organon & Co in Q4 2025 and held it in 1 quarter.
  • Garton & Associates Financial Advisors's Organon & Co position peaked at $179 in Q4 2025.
  • 607 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Garton & Associates Financial Advisors's 13F filing for Q1 2026, filed 11 May 2026.